Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 9 Pain 5 Breast Neoplasms 5 Neuralgia 4 Agnosia 4 Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1

Interventions

ulipristal acetate 18 Uterine Myomectomy 17 telapristone acetate 16 vilaprisan 11 Uterine Artery Embolization 10 relugolix 9 Leuprolide 9 asoprisnil 7 Mifepristone 7 ulipristal 6 estradiol, norethindrone drug combination 6 elagolix 6 Tranexamic Acid 6 Hysterectomy 6 Estradiol 6 Bupivacaine 6 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Saline Solution 4 Letrozole 4 Vitamin B 6 3 Radiofrequency Ablation 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡